蘭生股份(600826.SH)以5億元參與認購海通證券非公開發行股份
格隆匯8月6日丨蘭生股份(600826.SH)公佈,公司擬以金額不超過5億元參與投資海通證券股份有限公司(以下簡稱“海通證券公司”,股票代碼:600837)非公開發行人民幣普通股(A股)。
接海通證券公司通知,海通證券公司本次非公開發行股票事項已經完成,全部新增股份已於2020年8月5日在中國證券登記結算有限責任公司上海分公司辦理完畢登記託管手續。
海通證券公司本次非公開發行的發行對象最終確定為13名投資者,其中,公司認購股份數量為3906.25萬股,每股認購價格為12.80元,認購金額為5億元,認購的股份自海通證券公司本次非公開發行的股票上市之日起6個月內不得轉讓。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.